The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

17 May 2016 07:00

RNS Number : 3997Y
Tarsus Group PLC
17 May 2016
 

17 May 2016

 

Tarsus Group plc

Trading Update

Tarsus Group plc (LSE: TRS, "Tarsus" or the "Group"), the international business-to-business media group, is today providing a trading update on its current financial year to date.

Trading since the publication of the Annual Results on 2 March 2016 has been in-line with Board expectations with good performances to date across the Group's portfolio. Buyer growth on a like-for-like basis is tracking ahead of our internal target of 5%. We continue to execute our "Quickening the Pace" strategy and, as part of this, remain on course to run a larger number of replications in 2016.

Forward bookings for the full year are tracking 10%+ ahead on a like-for-like basis.

Emerging Markets

China continues to perform well with SIUF, Asia's largest underwear show, exceeding the 2015 edition. Buyer growth was up an excellent 13%.

Trading in Turkey was in-line with expectations with a particularly strong performance from Ideal Homex, the largest event in the period.

The Dubai portfolio continues to demonstrate growth. The largest event in the first half of the year was GESS (education), which performed very well with buyers increasing 17% over the previous edition.

Plastimagen, our plastics exhibition in Mexico, performed strongly. The replication of GESS into Mexico held its second edition and showed good progress, with buyer growth of 8%.

United States

The US portfolio continues to show solid growth. Our Medical business performed in line with expectations. This division continues to make good progress with its growth initiatives, with Painweek performing particularly well.

Douglas Emslie, Tarsus Group Managing Director, said:

"The Group has seen encouraging performances from its exhibitions so far this year in what is the quietest period in our two-year cycle and has strong forward bookings. Tarsus remains focused on delivering industry-leading buyer growth to its exhibitions and continues to invest in replicating its leading brands to accelerate growth in the medium term.

"We are mindful of the current global macroeconomic uncertainty and geopolitical risk and have budgeted accordingly. We remain positive about our trading prospects for 2016 and have a strong bookings position for our larger 2017 biennial events."

The Group plans to announce its Interim Results for the six months ended 30 June 2016 on 27 July 2016.

 

For further information:

 

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director

+44 (0) 20 8846 2700

Dan O'Brien, Group Finance Director

Neville Harris, Investor Relations

+44 (0)7909 976044

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUGGAUPQGMQ
Date   Source Headline
30th Jul 20147:00 amRNSHalf Yearly Report
11th Jul 20144:17 pmRNSAdditional Listing and Voting Rights
30th Jun 20145:05 pmRNSDirector/PDMR Shareholding
30th Jun 20145:00 pmRNSTotal Voting Rights
26th Jun 20147:00 amRNSNotice of interim results
24th Jun 20146:01 pmRNSDirector/PDMR Shareholding
24th Jun 201412:03 pmRNSDirectorate Change
23rd Jun 20143:44 pmRNSResult of AGM
20th Jun 20144:17 pmRNSDirector/PDMR Shareholding
5th Jun 20143:35 pmRNSScrip Dividend Circular
21st May 20145:26 pmRNSNotice of AGM
15th May 20147:00 amRNSInterim Management Statement
12th May 20141:00 pmRNSBlocklisting Interim Review
7th May 20147:46 amRNSNotice of IMS
30th Apr 20145:03 pmRNSTotal Voting Rights
24th Mar 20144:26 pmRNSDirector/PDMR Shareholding
18th Mar 20145:15 pmRNSCompletion of acquisition of SIUF
17th Mar 20145:10 pmRNSAnnual Financial Report
12th Mar 20144:35 pmRNSDirector/PDMR Shareholding
5th Mar 20144:15 pmRNSDirector/PDMR Shareholding
4th Mar 20147:00 amRNSFinal Results
26th Feb 201411:41 amRNSNotice of Results
19th Feb 20144:03 pmRNSHolding(s) in Company
13th Feb 201410:11 amRNSAdmission of Placing Shares
10th Feb 201411:08 amRNSCompletion of Placing
10th Feb 20147:00 amRNSProposed Placing of New Ordinary Shares
10th Feb 20147:00 amRNSAcquisitions
23rd Jan 201410:04 amRNSApplication for Admission
8th Jan 20147:01 amRNSCorporate Activity
8th Jan 20147:00 amRNSYear end trading update
19th Dec 20138:41 amRNSScrip Dividend
2nd Dec 20134:55 pmRNSTotal Voting Rights
26th Nov 20137:00 amRNSAcquisition
8th Nov 20132:55 pmRNSBlocklisting Interim Review
4th Nov 20137:00 amRNSInterim Management Statement
30th Sep 201311:13 amRNSTotal Voting Rights
16th Sep 20134:51 pmRNSDirector/PDMR Shareholding
22nd Aug 20137:00 amRNSInterim Financial Report
2nd Aug 20132:59 pmRNSTotal Voting Rights
2nd Aug 20132:58 pmRNSApplication for Admission
31st Jul 20137:01 amRNSDirectorate Change
31st Jul 20137:00 amRNSHalf Yearly Report
28th Jun 201311:35 amRNSTotal Voting Rights
28th Jun 20137:00 amRNSPre-close Trading Update
24th Jun 20133:06 pmRNSChange of Auditor
24th Jun 20133:04 pmRNSResult of AGM
19th Jun 201310:40 amRNSNotice of Results
6th Jun 20136:13 pmRNSCirc re. Scrip Dividend
23rd May 20135:31 pmRNSNotice of AGM
17th May 20137:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.